L.p. 667, - Net Worth and Insider Trading
L.p. 667, Net Worth
The estimated net worth of L.p. 667, is at least $17 Million dollars as of 2024-04-27. L.p. 667, is the Director of ACADIA Pharmaceuticals Inc and owns about 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $17 Million. Details can be seen in L.p. 667,'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that L.p. 667, has not made any transactions after 2013-01-18 and currently still holds the listed stock(s).
Transaction Summary of L.p. 667,
L.p. 667, Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L.p. 667, owns 21 companies in total, including IGM Biosciences Inc (IGMS) , Incyte Corp (INCY) , and Kodiak Sciences Inc (KOD) among others .
Click here to see the complete history of L.p. 667,’s form 4 insider trades.
Insider Ownership Summary of L.p. 667,
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IGMS | IGM Biosciences Inc | 2022-03-12 | director & 10 percent owner |
INCY | Incyte Corp | 2013-06-11 | director |
KOD | Kodiak Sciences Inc | 2022-01-21 | director & 10 percent owner |
PRLD | Prelude Therapeutics Inc | 2022-06-17 | director & 10 percent owner |
KNSA | Kiniksa Pharmaceuticals Ltd | 2022-06-29 | director |
BGNE | BeiGene Ltd | 2016-02-02 | director & 10 percent owner |
ACAD | ACADIA Pharmaceuticals Inc | 2013-01-18 | director |
SGEN | Seagen Inc | 2020-12-31 | director & 10 percent owner |
ALXN | Alexion Pharmaceuticals Inc | 2020-05-14 | director |
ZYME | Zymeworks Inc | 2020-03-16 | director |
NLTX | Neoleukin Therapeutics Inc | 2015-08-07 | 10 percent owner |
ACGN | Aceragen Inc | 2014-03-10 | director |
XOMA | XOMA Corp | 2012-07-19 | director |
MRTX | Mirati Therapeutics Inc | 2015-01-29 | 10 percent owner |
BCRX | BioCryst Pharmaceuticals Inc | 2013-08-01 | 10 percent owner |
XOMAO.PFD | XOMA Corp | 2012-07-19 | director |
TLIS | Talis Biomedical Corp | 2022-06-10 | director & 10 percent owner |
DBVT | DBV Technologies SA | 2022-06-13 | director & 10 percent owner |
SYRE | Spyre Therapeutics Inc | 2021-02-23 | director |
TCRX | TScan Therapeutics Inc | 2022-05-10 | director & 10 percent owner |
MDGL | Madrigal Pharmaceuticals Inc | 2023-06-15 | director |
L.p. 667, Latest Holdings Summary
L.p. 667, currently owns a total of 1 stock. L.p. 667, owns 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 18, 2013, with a value of $17 Million.
Latest Holdings of L.p. 667,
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACAD | ACADIA Pharmaceuticals Inc | 2013-01-18 | 1,045,475 | 16.71 | 17,469,887 |
Holding Weightings of L.p. 667,
L.p. 667, Form 4 Trading Tracker
According to the SEC Form 4 filings, L.p. 667, has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on January 18, 2013, which brought L.p. 667, around $0.
Insider Trading History of L.p. 667,
- 1
L.p. 667, Trading Performance
L.p. 667, Ownership Network
Ownership Network List of L.p. 667,
Ownership Network Relation of L.p. 667,
L.p. 667, Owned Company Details
What does IGM Biosciences Inc do?
Who are the key executives at IGM Biosciences Inc?
L.p. 667, is the director & 10 percent owner of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include director & 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Steven Weber , and Chief Medical Officer Chris H Takimoto .
IGM Biosciences Inc (IGMS) Insider Trades Summary
Over the past 18 months, L.p. 667, made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,918 shares made by George Gauthier , a net sale of 20,975 shares made by Bruce Keyt , and a net sale of 14,987 shares made by Lisa Lynn Decker .
In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc (IGMS) in total and bought 395,317 shares, with a net purchase of 367,192 shares. During the past 18 months, 204,745 shares of IGM Biosciences Inc (IGMS) were sold and 1,190,933 shares were bought by its insiders, resulting in a net purchase of 986,188 shares.
IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
IGM Biosciences Inc Insider Transactions
L.p. 667, Mailing Address
Above is the net worth, insider trading, and ownership report for L.p. 667,. You might contact L.p. 667, via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.